Molecular genetics of late-onset Alzheimer's disease

被引:130
作者
Kamboh, MI [1 ]
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA
关键词
D O I
10.1046/j.1529-8817.2004.00110.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Late-onset Alzheimer's disease (AD) is a complex and multifactorial disease with the possible involvement of several genes. Apolipoprotein E (APOE), especially the APOE* 4 allele, has been established as a strong susceptibility marker that accounts for nearly 30% of the risk in late-onset AD. However, as the APOE* 4 allele is neither necessary nor sufficient for the development of AD, it emphasizes the involvement of other genetic and/or environmental factors which, alone or in conjunction with APOE* 4, can modify the risk of AD. Recently, genome-wide linkage or linkage disequilibrium studies on late-onset AD have provided informative data for the existence of multiple putative genes for AD on several chromosomes, with the strongest evidence on chromosomes 12, 10, 9 and 6. This paper attempts to review the current progress on the identification of additional genetic loci for late-onset AD.
引用
收藏
页码:381 / 404
页数:24
相关论文
共 133 条
[21]   No association detected between very-low-density lipoprotein receptor (VLDL-R) and late-onset Alzheimer's disease in Hong Kong Chinese [J].
Chen, L ;
Baum, L ;
Ng, HK ;
Chan, YS ;
Mak, YT ;
Woo, J ;
Chiu, H ;
Pang, CP .
NEUROSCIENCE LETTERS, 1998, 241 (01) :33-36
[22]   Lack of association of trinucleotide repeat polymorphisms in the very-low-density lipoprotein receptor gene with Alzheimer's disease [J].
Chung, H ;
Roberts, CT ;
Greenberg, S ;
Rebeck, GW ;
Christie, R ;
Wallace, R ;
Jacob, HJ ;
Hyman, BT .
ANNALS OF NEUROLOGY, 1996, 39 (06) :800-803
[23]  
Collins JS, 2000, AM J MED GENET, V96, P823, DOI 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO
[24]  
2-I
[25]  
Combarros O, 1998, ACTA NEUROL SCAND, V98, P140
[26]   A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease [J].
Crawford, FC ;
Freeman, MJ ;
Schinka, JA ;
Abdullah, LI ;
Gold, M ;
Hartman, R ;
Krivian, K ;
Morris, MD ;
Richards, D ;
Duara, R ;
Anand, R ;
Mullan, MJ .
NEUROLOGY, 2000, 55 (06) :763-768
[27]   HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease [J].
Curran, M ;
Middleton, D ;
Edwardson, J ;
Perry, R ;
McKeith, I ;
Morris, C ;
Neill, D .
NEUROREPORT, 1997, 8 (06) :1467-1469
[28]   The number of trait loci in late-onset Alzheimer disease [J].
Daw, EW ;
Payami, H ;
Nemens, EJ ;
Nochlin, D ;
Bird, TD ;
Schellenberg, GD ;
Wijsman, EM .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (01) :196-204
[29]   Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein [J].
De Strooper, B ;
Saftig, P ;
Craessaerts, K ;
Vanderstichele, H ;
Guhde, G ;
Annaert, W ;
Von Figura, K ;
Van Leuven, F .
NATURE, 1998, 391 (6665) :387-390
[30]   Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease:: evidence of effect modification by apolipoprotein E (APOE) [J].
Edland, SD ;
Vriesé, FWD ;
Compton, D ;
Smith, GE ;
Ivnik, R ;
Boeve, BF ;
Tangalos, EG ;
Petersen, RC .
NEUROSCIENCE LETTERS, 2003, 345 (01) :21-24